|
|||
|
DRUGS & SUPPLEMENTS
|
Active ingredient: Mannitol
How often in a day do you take medicine? How many times? |
Mannitol uses
- Indications and usage
- Contraindications
- Warnings
- Precautions
- Adverse reactions
- Overdosage
- Dosage and administration
- How supplied
- Directions for use of pic (plastic irrigation containers)
INDICATIONS AND USAGE
5% Mannitol is indicated for use as a urologic irrigation fluid for transurethral prostatic resection and other transurethral surgical procedures.
CONTRAINDICATIONS
5% Mannitol is not for injection. It is contraindicated in patients with anuria.
WARNINGS
FOR UROLOGIC IRRIGATION ONLY. NOT FOR INJECTION.
Solutions for urologic irrigation must be used with caution in patients with severe cardiopulmonary or renal dysfunction.
Since irrigating fluids used during transurethral prostatectomy have been demonstrated to enter the systemic circulation in relatively large volumes, any irrigation solution must be regarded as a systemic drug.
Absorption of large amounts of fluids containing Mannitol and the resultant osmotic diuresis may significantly affect cardiopulmonary and renal dynamics.
Do not warm above 150°F (66°C)
After opening container, its contents should be used promptly to minimize the possibility of bacterial growth or pyrogen formation.
Discard unused portion of irrigating solution since it contains no preservative.
PRECAUTIONS
General
Use aseptic technique when preparing and administering sterile irrigation solutions.
Use only if solution is clear and container and seal are intact.
Cardiovascular status, especially in patients with cardiac disease, should be carefully determined before and during transurethral resection of the prostate when using 5% Mannitol as an irrigant. The fluid absorbed into the systemic circulation via severed prostatic veins may produce significant extracellular fluid expansion and lead to fulminating congestive heart failure.
Shift of sodium-free intracellular fluid into the extracellular compartment following systemic absorption of 5% Mannitol may lower serum sodium concentration and aggravate pre-existing hyponatremia.
Excessive loss of water and electrolytes may lead to serious imbalances. Continuous administration of 5% Mannitol may cause loss of water in excess of electrolytes and produce hypernatremia.
Sustained diuresis from transurethral irrigation with 5% Mannitol may obscure and intensify inadequate hydration or hypovolemia.
When used for irrigation via appropriate irrigation equipment, the administration set should be attached promptly. Unused portions should be discarded and a fresh container of appropriate size used for the start up of each cycle or repeat procedure. For repeated irrigations of urethral catheters, a separate container should be used for each patient.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Studies with 5% Mannitol Irrigation have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.
Pregnancy
Teratogenic Effects
Pregnancy Category C
Animal reproduction studies have not been conducted with 5% Mannitol Irrigation. It is also not known whether 5% Mannitol Irrigation can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 5% Mannitol Irrigation should be given to a pregnant woman only if clearly needed.
Nursing Mothers
Caution should be exercised when 5% Mannitol Irrigation is administered to a nursing woman.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established.
Geriatric Use
Clinical studies of 5% Mannitol Irrigation did not include a sufficient number of patients age 65 years and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. See WARNINGS .
ADVERSE REACTIONS
Occasional adverse reactions to intravenous Mannitol infusions have been reported. These include fluid and electrolyte disturbances, such as acidosis, electrolyte loss, marked diuresis, urinary retention, edema, dryness of the mouth, thirst and dehydration, cardiovascular/pulmonary disorders such as pulmonary congestion, hypotension, tachycardia, angina-like pain, and thrombophlebitis, and other general reactions such as blurred vision, convulsions, nausea, vomiting, rhinitis, chills, vertigo, backache, and urticaria.
If an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination, if deemed necessary.
OVERDOSAGE
In the event of dehydration or fluid or solute overload, discontinue the irrigant, evaluate the patient and institute appropriate corrective treatment. See WARNINGS , PRECAUTIONS, and ADVERSE REACTIONS .
DOSAGE AND ADMINISTRATION
As required for urologic irrigation.
5% Mannitol Irrigation should be administered only by the appropriate transurethraI urologic instrumentation.
Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.
Solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permits.
HOW SUPPLIED
5% Mannitol Irrigation is supplied sterile and nonpyrogenic in PIC (Plastic Irrigation Containers). The 2000 mL containers are packaged 8 per case and the 4000 mL containers are packaged 4 per case.
| NDC | Cat. No. | Size |
|---|---|---|
| 5% Mannitol Irrigation (Canada DIN 01963953) | ||
| 0264-2303-50 | R6515-01 | 2000 mL |
| 0264-2303-70 | R6517 | 4000 mL |
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.
Do not warm above 150°F (66°C).
Rx only
Revised: March 2009
PIC is a trademark of B. Braun Medical Inc.
Directions for Use of PIC
Not for injection.
Aseptic technique is required.
1. Caution – Before use, perform the following checks:
(a) Read the label. Ensure solution is the one ordered and is within the expiration date.
(b) Invert container and inspect the solution in good light for cloudiness, haze, or particulate
matter; check the container for leakage or damage. Any container which is suspect
should not be used.
Use only if solution is clear and container and seal are intact.
Single dose container.
2. Outer Closure Removal – Grasp the container with one hand and turn the breakaway ring
counterclockwise with the other hand until slight resistance is felt. Then, twisting the
container in the opposite direction, turn the breakaway ring sharply until the entire outer
cap is loose and can be lifted off.
3. Connect the administration set through the sterile port according to set instructions or
remove screw cap and pour.
4. Do not warm above 150°F to assure minimal bottle distortion. Keep bottles upright.
Figure 1 Figure 2
B. Braun Medical Inc.
Irvine, CA 92614-5895 USA
Made in USA
In Canada, distributed by:
B. Braun Medical Inc.
Scarborough, Ontario M1H 2W4
Y36-002-697
5% Mannitol Irrigation
For Urologic Irrigation
REF R6515-01
NDC 0264-2303-50
DIN 01963953
2000 mL
Lot
Exp.
Each 100 mL contains:
Mannitol USP 5 g
Water for Injection USP qs
pH: 5.5 (4.5-7.0)
Calc. Osmolarity: 275 mOsmol/liter
Not for Injection: Use only if
solution is clear and container
and seal are intact.
Sterile, nonpyrogenic.
Single dose container.
Warning: Do not warm above
150°F (66°C).
Recommended Storage:
Room temperature (25°C).
Avoid excessive heat.
Protect from freezing.
See Package Insert.
Rx only
PVC-free and DEHP-free
B. Braun Medical Inc.
Irvine, CA 92614-5895 USA
Made in USA
In Canada, distributed by:
B. Braun Medical Inc.
Scarborough, Ontario M1H 2W4
Y37-002-334
Mannitol available forms, composition, doses:
| Price | |
| Injectable; Infusion; Mannitol 100 mg / ml | |
| Injectable; Infusion; Mannitol 200 mg / ml | |
| Injectable; Infusion; Mannitol 50 mg / ml | |
| Injectable; Injection; Mannitol 10% | |
| Injectable; Injection; Mannitol 15% | |
| Injectable; Injection; Mannitol 20 mg / ml | |
| Injectable; Injection; Mannitol 20% | |
| Injectable; Injection; Mannitol 25% | |
| Injectable; Injection; Mannitol 250 mg / ml | |
| Injectable; Injection; Mannitol 5% | |
| Mannitol 10% iv solution | 0.02 USD |
| Mannitol 15% iv solution | 0.04 USD |
| Mannitol 20% iv solution | 0.04 USD |
| Mannitol 25% vial | 0.03 USD |
| Mannitol 5% iv solution | 0.02 USD |
| Mannitol powder | 0.05 USD |
| Osmitrol 10% iv solution | 0.07 USD |
| Osmitrol 15% iv solution | 0.07 USD |
| Osmitrol 20% iv solution | 0.15 USD |
| Osmitrol 5% iv solution | 0.03 USD |
| Resectisol 5% solution | 0.01 USD |
Indications and Usages:
ATC codes:
ICD-10 codes:
Mannitol destination | category:
Drugs with same active ingredients (Pharmaceutical companies):
References
- Dailymed."MANNITOL IRRIGANT [B. BRAUN MEDICAL INC.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Frequently asked Questions
Can i drive or operate heavy machine after consuming Mannitol?Depending on the reaction of the Mannitol after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Mannitol not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.
Is Mannitol addictive or habit forming?Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
Review
sdrugs.com conducted a study on Mannitol, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Mannitol consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.Visitor reports
Visitor reported useful
No survey data has been collected yetVisitor reported side effects
No survey data has been collected yetVisitor reported price estimates
No survey data has been collected yetVisitor reported frequency of use
No survey data has been collected yetOne visitor reported doses
What is the dose of Mannitol drug you are taking?According to the survey conducted among sdrugs.com website users, the maximum number of people are using the following dose 51-100mg. Few medications come in only one or two doses. Few are specific for adult dose and child dose. The dose of the medicine given to the patient depends on the severity of the symptom/disease. There can be dose adjustments made by the doctor, based on the progression of the disease. Follow-up is important.
| Visitors | % | ||
|---|---|---|---|
| 51-100mg | 1 | 100.0% | |
Visitor reported time for results
No survey data has been collected yetVisitor reported administration
No survey data has been collected yetVisitor reported age
No survey data has been collected yetVisitor reviews
There are no reviews yet. Be the first to write one! |
The information was verified by Dr. Rachana Salvi, MD Pharmacology